Thursday, June 6 | 11th International Cord Blood Symposium

Scientific Program
Registration

Registration closes June 2nd. Attendees are advised to take advantage of the reduced rates:
Exhibitor Prospectus
Call for Abstracts

Accepted abstracts are scheduled for poster presentation:
Hotel Reservations

Favorable rates have been secured at the Hyatt Regency San Francisco. Reservations must be made no later than May 14 to secure the preferred room rates:

Regenerative Medicine & Cellular Therapy

Session IA

7:55 – 9:50 AM

The Potential of Cord Blood Stem Cells for Use in Regenerative Medicine

Chair: Mahendra Rao

7:55 – 8:10 AM Welcome and Introduction

Joanne Kurtzberg, MD, Duke University

8:10 – 8:30 AM What are the Opportunities for Cord Blood Derived Products in Regenerative Medicine?

Mahendra Rao, MD, PhD, National Institutes of Health Center for Regenerative Medicine

8:30 – 8:50 AM Deriving Mesenchymal Stem Cells from Human Amniotic Fluid - Potential for an Allogeneic Cellular Therapy Product

Julie G. Allickson, PhD, Wake Forest University

8:50 – 9:20 AM MSC-like Cells from Human Umbilical Cord Tissue - Roadmap to Clinical Utility in Regenerative Therapies

Morey Kraus, ViaCord

9:20 – 9:50 AM Ex Vivo Modulation Strategies to Enhance the Therapeutic Potential of Cord Blood

Dan Shoemaker, PhD, Fate Therapeutics

9:50 – 10:10 AM
COFFEE BREAK - PACIFIC CONCOURSE

Session IB

10:10 AM – 12:00 PM

Using Cord Blood to Heal the Brain

Chairs: Sidhartha Tan & Wise Young

10:10 – 10:30 AM Efficacy of Cord Blood Stem Cells in a Baby Rabbit Model of Hypoxic-Ischemic Encephalopathy

Sidhartha Tan, MD, University of Chicago

10:30 – 10:50 AM Combined Hematopoietic Stem Cell Transplantation, Gene and Substrate Reduction Therapy Show Superior Results to HSCT in a Murine Model of Krabbe Disease

Mark Sands, PhD, Washington University School of Medicine in St. Louis

10:50 – 11:10 AM Umbilical Cord Blood Mononuclear Cell Therapy of Spinal Cord Injury, Stroke, Myocardial Infarction, and Optic Nerve Atrophy

Wise Young, MD, PhD, Rutgers University

11:10 – 11:30 AM High Resolution Tracktography is a Highly Sensitive Biomarker to Study Myelination in the Brain

Jessica Sun, MD, Duke University

11:30 – 12:00 PM Debate: Can Off-the-shelf Allogenic Cord Blood Products Bridge Hematopoiesis after Marrow Injury

Colleen Delaney, MD, Fred Hutchinson Cancer Research Center

Joanne Kurtzberg, MD, Duke University

12:00 – 1:00 PM
LUNCH - PACIFIC CONCOURSE

Session IIA

1:00 – 2:50 PM

Envisioning the Future Landscape for Novel Applications of Cord Blood in Regenerative Medicine

Chairs: Julie Allickson & Andrew Balber

1:00 – 1:30 PM What is the Potential for Banked Cord Blood in the Field of Regenerative Medicine?

Joanne Kurtzberg, MD, Duke University

1:30 – 2:00 PM Overcoming Allogeneic Barriers to Cellular Therapies with Banked Cord Blood

Alison Willing, PhD, University of South Florida

2:00 – 2:30 PM Deriving Induced Pluripotent Stem Cells from Small Samples of Cryopreserved Cord Blood

Scott Noggle, PhD, New York Stem Cell Foundation

2:30 – 2:50 PM Panel Discussion - Allickson, Balber, Kurztberg, Willing, Noggle

2:50 – 3:10 PM
COFFEE BREAK - PACIFIC CONCOURSE

Session IIB

3:10 – 5:00 PM

Cord Blood Transplantation for Non-Malignant Diseases

Chairs: Shalini Shenoy & Jennifer Willert

3:10 – 3:40 PM Hematopoietic Stem-Cell Transplantation for Sickle Cell Disease

Shalini Shenoy, MD, Washington University School of Medicine in St. Louis

3:40 – 4:00 PM Nicord for Cord Blood Transplantation in Patients with Sickle Cell Disease

Joanne Kurtzberg, MD, Duke University

4:00 – 4:20 PM Late Outcomes of Cord Blood Transplantation for Patients with Hurler Syndrome

Jaap Boelens, MD, PhD, University Medical Center Utrecht

4:20 – 4:40 PM Functional Outcomes of Cord Blood Transplantation for Patients with Metachromatic Leukodystrophy

Maria Escolar, MD, University of Pittsburgh School of Medicine

4:40 – 5:00 PM Panel Discussion - Shenoy, Willert, Kurtzberg, Boelens, Escolar

5:00 PM
ADJOURN

View Friday's Program

7:55 – 8:10 AM	Welcome and Introduction Joanne Kurtzberg, MD, Duke University

8:10 – 8:30 AM	What are the Opportunities for Cord Blood Derived Products in Regenerative Medicine? Mahendra Rao, MD, PhD, National Institutes of Health Center for Regenerative Medicine

8:30 – 8:50 AM	Deriving Mesenchymal Stem Cells from Human Amniotic Fluid - Potential for an Allogeneic Cellular Therapy Product Julie G. Allickson, PhD, Wake Forest University

8:50 – 9:20 AM	MSC-like Cells from Human Umbilical Cord Tissue - Roadmap to Clinical Utility in Regenerative Therapies Morey Kraus, ViaCord
9:20 – 9:50 AM	Ex Vivo Modulation Strategies to Enhance the Therapeutic Potential of Cord Blood Dan Shoemaker, PhD, Fate Therapeutics

9:50 – 10:10 AM	COFFEE BREAK - PACIFIC CONCOURSE

10:10 – 10:30 AM	Efficacy of Cord Blood Stem Cells in a Baby Rabbit Model of Hypoxic-Ischemic Encephalopathy Sidhartha Tan, MD, University of Chicago

10:30 – 10:50 AM	Combined Hematopoietic Stem Cell Transplantation, Gene and Substrate Reduction Therapy Show Superior Results to HSCT in a Murine Model of Krabbe Disease Mark Sands, PhD, Washington University School of Medicine in St. Louis


10:50 – 11:10 AM	Umbilical Cord Blood Mononuclear Cell Therapy of Spinal Cord Injury, Stroke, Myocardial Infarction, and Optic Nerve Atrophy Wise Young, MD, PhD, Rutgers University

11:10 – 11:30 AM	High Resolution Tracktography is a Highly Sensitive Biomarker to Study Myelination in the Brain Jessica Sun, MD, Duke University

11:30 – 12:00 PM	Debate: Can Off-the-shelf Allogenic Cord Blood Products Bridge Hematopoiesis after Marrow Injury Colleen Delaney, MD, Fred Hutchinson Cancer Research Center Joanne Kurtzberg, MD, Duke University
12:00 – 1:00 PM	LUNCH - PACIFIC CONCOURSE

1:00 – 1:30 PM	What is the Potential for Banked Cord Blood in the Field of Regenerative Medicine? Joanne Kurtzberg, MD, Duke University
1:30 – 2:00 PM	Overcoming Allogeneic Barriers to Cellular Therapies with Banked Cord Blood Alison Willing, PhD, University of South Florida
2:00 – 2:30 PM	Deriving Induced Pluripotent Stem Cells from Small Samples of Cryopreserved Cord Blood Scott Noggle, PhD, New York Stem Cell Foundation

2:30 – 2:50 PM	Panel Discussion - Allickson, Balber, Kurztberg, Willing, Noggle

2:50 – 3:10 PM	COFFEE BREAK - PACIFIC CONCOURSE

3:10 – 3:40 PM	Hematopoietic Stem-Cell Transplantation for Sickle Cell Disease Shalini Shenoy, MD, Washington University School of Medicine in St. Louis

3:40 – 4:00 PM	Nicord for Cord Blood Transplantation in Patients with Sickle Cell Disease Joanne Kurtzberg, MD, Duke University

4:00 – 4:20 PM	Late Outcomes of Cord Blood Transplantation for Patients with Hurler Syndrome Jaap Boelens, MD, PhD, University Medical Center Utrecht

4:20 – 4:40 PM	Functional Outcomes of Cord Blood Transplantation for Patients with Metachromatic Leukodystrophy Maria Escolar, MD, University of Pittsburgh School of Medicine

4:40 – 5:00 PM	Panel Discussion - Shenoy, Willert, Kurtzberg, Boelens, Escolar

5:00 PM	ADJOURN

Presented by

Contributing Partners

Home
Scientific Program
Exhibitors & Contributing Partners
Events
Registration
Contact
Past Symposia

©2013 Cord Blood Symposium

Unless explicitly stated otherwise, all rights including those in copyright in the content of this website are owned by or controlled for these purposes by the Cord Blood Forum. Except as otherwise expressly permitted under copyright law or the Cord Blood Forum's Terms of Use, the content of this site may not be copied, reproduced, republished, downloaded, posted, broadcast or transmitted in any way without first obtaining Cord Blood Forum's written permission or that of the copyright owner.